Loading company…
Single-cell Biotech develops instruments, reagents, and software for single-cell analysis.
Founded in 2014 and based in Qingdao, China, Single-cell Biotech develops single-cell analyzers and related reagents and consumables. Its instruments, kits, chips, and software support single-cell imaging, sorting, sequencing, and culture for fields including precision medicine and bioresource research. In January 2026, the company raised approximately CNY 100 million in Series A++ funding led by CASVC Investment Management, with participation from Zheshang Capital Management and Shandong Finance Investment Group.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in